Avrupa Birliği -
İspanyolca -
EMA (European Medicines Agency)
pandemrix
glaxosmithkline biologicals s.a. - virus de la influenza dividido inactivado, que contiene antígeno equivalente a una cepa derivada de a / california / 07/2009 (h1n1) utilizada nymc x-179a - influenza, human; immunization; disease outbreaks - vacunas contra la gripe - profilaxis de la influenza causada por el virus a (h1n1) v 2009. pandemrix solo debe usarse si las vacunas anuales recomendadas trivalentes / tetravalentes contra la influenza estacional no están disponibles y si se considera necesaria la inmunización contra (h1n1) v (ver secciones 4).. 4 y 4. pandemrix debe ser utilizado de acuerdo con las directrices oficiales.
Peru -
İspanyolca -
DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
procthyl 5% + 1% unguento
instituto quimioterapico s.a. - laboratorio - unguento - por gramo 5.00 mg - - policresuleno
Avrupa Birliği -
İspanyolca -
EMA (European Medicines Agency)
coxevac
ceva santé animale - vacuna inactivada de coxiella burnetii, cepa nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.
Küba -
İspanyolca -
CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)
dormicum
cenexi sas, fontenay-sous-bois, francia - midazolam - solución inyectable, im, iv, rectal - 15 mg/3 ml
İspanya -
İspanyolca -
AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
diminex antitusigeno adolescentes supositorios
laboratorios vinas s.a. - codeina fosfato; clorciclizina hidrocloruro; cineol; guaifenesina - supositorio - 5 mg/5 mg/50 mg/50 mg - codeina fosfato 5 mg; clorciclizina hidrocloruro 5 mg; cineol 50 mg; guaifenesina 50 mg - derivados del opio y expectorantes